Ginkgo Bioworks Holdings (DNA) Leases (2020 - 2026)

Ginkgo Bioworks Holdings (DNA) has 7 years of Leases data on file, last reported at $353.8 million in Q1 2026.

• For the quarter ending Q1 2026, Leases fell 7.72% year-over-year to $353.8 million; the trailing twelve-month figure through Mar 2026 stood at $353.8 million (down 7.72% YoY), and the FY2025 full-year result was $360.9 million, down 8.5% from the prior year.
• Leases for Q1 2026 stood at $353.8 million, down from $360.9 million in the prior quarter.
• Across five years, Leases topped out at $418.0 million in Q2 2024 and bottomed at $206.8 million in Q4 2023.
• The 5-year median for Leases is $379.6 million (2025), against an average of $357.9 million.
• The widest annual swing landed in 2022, when Leases surged 9674.68%; it then sank 48.4% in 2023.
• A 5-year view of Leases shows it stood at $400.8 million in 2022, then slumped by 48.4% to $206.8 million in 2023, then soared by 90.73% to $394.4 million in 2024, then decreased by 8.5% to $360.9 million in 2025, then decreased by 1.97% to $353.8 million in 2026.
• The last three Leases figures came in at $353.8 million (Q1 2026), $360.9 million (Q4 2025), and $368.2 million (Q3 2025), per Business Quant data.

Peer Comparison